欢迎联系客服人员:
客服:13918293035
QQ:3001034031
客服:13917991872
QQ:3001005926
客服:15102117276
QQ:3001090745
客服:18217024652
QQ:3001084617
客服:13816009161
QQ:3001086693
客服:13795317828
QQ:3001080377
客服:15800340161
QQ:3001010259
客服:13651665725
QQ:3001028570
客服:18918753302
QQ:3001080321
客服:13916577892
QQ:3001007248
客服:15316187026
QQ:3004961006
客服:18901678489
QQ:3004909899
客服:18018502489
QQ:3004930012
客服:18019219489
QQ:3004900398
电话:021-58979353
电话:021-68920155
电话:021-68404353
邮箱:info@zzsrm.com
邮箱:tech@zzbioco.com
货号 | 简称 | 化学名 | CAS | 纯度 |
ZS-31000 | p-SCN-Bn-TCMC | S-2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraaza-1,4,7,10-tetra(2-carbamoylmethyl)cyclododecane; | .282097-63-6 | ≥ 94% |
ZS-31001 | p-NO2-Bn-Cyclen | S-2-(4-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane; | .116052-96-9 | ≥ 94% |
ZS-31002 | DOTAM-mono-acid | 1,4,7,10-Tetraazacyclododecane-1,4,7-tri(carbamoylmethyl)-10-acetic acid; | N/A | ≥ 95% |
ZS-31003 | p-NO2-Bn-DOTA | S-2-(4-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane tetraacetic acid; | .116052-88-1 | ≥ 94% |
ZS-31004 | p-NH₂-Bn-DOTA | S-2-(4-Aminobenzyl)-1,4,7,10-tetraazacyclododecane tetraacetic acid; | .181065-46-3 | ≥ 94% |
ZS-31005 | p-NH₂-Bn-DOTA-tetra(t-Bu ester) | S-2-(4-Aminobenzyl)-1,4,7,10-tetraazacyclododecane tetra-tert-butylacetate; | N/A | ≥ 94% |
ZS-31006 | p-SCN-Bn-DOTA | S-2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane tetraacetic acid; | .127985-74-4 | ≥ 94% |
ZS-31007 | DOTA-tris (t-Bu ester) | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-acetic acid; | .137076-54-1 | ≥ 95% |
ZS-31008 | DOTAGA-tetra (t-Bu ester) | 2-[1,4,7,10-Tetraazacyclododecane-4,7,10-tris(t-butyl acetate)]-pentanedioic acid-1t-butyl ester; | .306776-79-4 | ≥ 94% |
ZS-31009 | DOTA-mono-NHS tris (t-Bu ester) | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-succinimidyl acetate; | .819869-77-7 | ≥ 94% |
ZS-31010 | Maleimido-mono-amide-DOTA-tris (t-Bu ester) | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-maleimidoethylacetamide; | N/A | ≥ 94% |
ZS-31011 | Maleimido-mono-amide-DOTA | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidoethylacetamide; | .1006711-09-5 | ≥ 94% |
ZS-31012 | Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester) | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-(N-a-Fmoc-N-e-acetamido-L-lysine); | .479081-06-6 | ≥ 94% |
ZS-31013 | Butyne-DOTA-tris(t-butyl ester) | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butyl acetate)-10-(3-butynylacetamide); | N/A | ≥ 94% |
ZS-31014 | 2-Aminoethyl-mono-amide-DOTA-tris(t-Bu ester) | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butyl-acetate)-10-(aminoethylacetamide); | N/A | ≥ 94% |
ZS-31015 | Azido-mono-amide-DOTA-tris(t-Bu ester) | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-(azidopropyl ethylacetamide); | N/A | ≥ 94% |
ZS-31016 | 4-Aminobutyl-DOTA-tris (t-butyl ester) | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butyl acetate)-10-(4-aminobutyl)acetamide; | N/A | ≥ 94% |
ZS-31017 | DOTA-NHS-ester | 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid mono-N-hydroxysuccinimide ester; | .170908-81-3 | ≥ 90% |
ZS-31018 | DO3A-Thiol | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(2-thioethyl)acetamide; | .865470-67-3 | ≥ 94% |
ZS-31019 | Butyne-DOTA | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(3-butynylacetamide); | N/A | ≥ 94% |
ZS-31020 | Azido-mono-amide-DOTA | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(azidopropyl ethylacetamide); | .1227407-76-2 | ≥ 94% |
ZS-31021 | 4-Aminobutyl-DOTA | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(4-aminobutyl)acetamide; | N/A | ≥ 94% |
ZS-31023 | p-NH₂-Bn-DTPA-penta (t-Bu ester) | S-2-(4-Aminobenzyl)-diethylenetriamine penta-tert-butyl acetate; | .205956-41-0 | ≥ 94% |
ZS-31024 | p-SCN-Bn-DTPA | S-2-(4-Isothiocyanatobenzyl)-diethylenetriamine pentaacetic acid; | .102650-30-6 | ≥ 94% |
ZS-31025 | p-NH₂-Bn-CHX-A”-DTPA | [(R)-2-Amino-3-(4-aminophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid; | .1105741-38-5 | ≥ 94% |
ZS-31026 | p-SCN-Bn-CHX-A”-DTPA | [(R)-2-Amino-3-(4-isothiocyanatophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid; | .157380-45-5 | ≥ 94% |
ZS-31027 | DTPA-tetra (t-Bu ester) | Diethylenetriamine-N,N,N”,N”-tetra-tert-butyl acetate-N’-acetic acid; | .174267-71-1 | ≥ 94% |
ZS-31028 | Maleimido-mono-amide-DTPA | Diethylenetriamine-N,N,N”,N”-tetra- acetic acid-N’-maleimidoethylacetamide; | N/A | ≥ 94% |
ZS-31029 | p-NH₂-Bn-PCTA | 3,6,9,15-Tetraazabicyclo[9.3.1] pentadeca-1(15),11,13-triene-4-S-(4-aminobenzyl)-3,6,9-triacetic acid; | N/A | ≥ 94% |
ZS-31030 | p-SCN-Bn-PCTA | 3,6,9,15-Tetraazabicyclo[9.3.1] pentadeca-1(15),11,13-triene-4-S-(4-isothiocyanatobenzyl)-3,6,9-triacetic acid; | N/A | ≥ 94% |
ZS-31031 | p-NH₂-Bn-oxo-DO3A | 1-Oxa-4,7,10-tetraazacyclododecane-5-S-(4-aminobenzyl)-4,7,10-triacetic acid; | N/A | ≥ 94% |
ZS-31032 | p-SCN-Bn-oxo-DO3A | 1-Oxa-4,7,10-tetraazacyclododecane-5-S-(4-isothiocyantobenzyl)-4,7,10-triacetic acid; | N/A | ≥ 94% |
ZS-31033 | p-NH2-Bn-NOTA | 2-S-(4-Aminobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid; | .142131-37-1 | ≥ 94% |
ZS-31034 | p-SCN-Bn-NOTA | 2-S-(4-Isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid; | .147597-66-8 | ≥ 94% |
ZS-31035 | NO2A-Butyne-bis (t-Butyl ester) | 1,4,7-Triazacyclononane-1,4-bis(t-butylacetate)-7-(3-butynylacetamide); | N/A | |
ZS-31036 | NOTA-bis(t-Bu ester) | 1,4,7-Triazacyclononane-1,4-bis-tert-butyl acetate-7-acetic acid; | .1161415-28-6 | ≥ 95% |
ZS-31037 | Maleimido-mono-amide-NOTA | 1,4,7-Triazacyclononane-1,4-bis-acetic acid-7-maleimidoethylacetamide; | N/A | ≥ 94% |
ZS-31038 | NO2A-Butyne | 1,4,7-Triazacyclononane-1,4-bis(acetic acid)-7-(3-butynylacetamide); | N/A | ≥ 94% |
ZS-31039 | NO2A-Azide | 1,4,7-Triazacyclononane-1,4-bis(acetic acid)-7-(3-azidopropylacetamide); | N/A | ≥ 94% |
ZS-31040 | p-SCN-Bn-Deferoxamine | 1-(4-isothiocyanatophenyl)-3-[6,17-dihydroxy-7,10,18,21-tetraoxo-27-(N-acetylhydroxylamino)- 6,11,17, 22- tetraazaheptaeicosine] thiourea; | .1222468-90-7 | ≥ 94% |
ZS-31041 | Deferoxamine-maleimide | N-(3,11,14,22,25,33-hexaoxo-4,10,15,21,26,32-hexaaza-10,21,32- trihydroxytetratriacontane)maleimide; | N/A | ≥ 94% |